Rébecca Sberro‐Soussan

Author

Also Known As

E Todesco, R Sberro-Soussan, R. Sberro Soussan, R. Sberro-Soussan, R. Sberro‐Soussan, Rebecca Sberro Soussan, Rebecca Sberro-Soussan, Rebecca Sberro‐Soussan, Rébecca Sberro Soussan, Rébecca Sberro-Soussan

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Université Paris Cité Hôpital Necker-Enfants Malades Assistance Publique – Hôpitaux de Paris Inserm Délégation Paris 5

About

Rébecca Sberro‐Soussan is an author at Université Paris Cité specializing in medicine, kidney transplant, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	539
2	Blood Transplantation	2	2	96
3	Health Sciences	1	1	31
4	Public Health	1	1	78
5	Cell Biology	1	1	131

Rébecca Sberro‐Soussan

Publications

Citations

H-Index

Page 1

	Year	Citations
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome Christophe Legendre, Christoph Licht, Petra Muus, New England Journal of Medicine	2013	1.5K
The Kidney as a Reservoir for HIV-1 after Renal Transplantation Guillaume Canaud, Nathalie Dejucq‐Rainsford, Véronique Avettand-Fènoël, Journal of the American Society of Nephrology Renal PathologyImmunologyRenal TransplantationImmunotherapyHuman Retrovirus	2013	131
Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome Julien Zuber, Marie Frimat, Sophie Caillard, Journal of the American Society of Nephrology	2019	122
Bortezomib as the Sole Post‐Renal Transplantation Desensitization Agent Does Not Decrease Donor‐Specific Anti‐HLA Antibodies Rébecca Sberro‐Soussan, Julien Zuber, Caroline Suberbielle‐Boissel, American Journal of Transplantation	2010	115
Eculizumab Improves Posttransplant Thrombotic Microangiopathy Due to Antiphospholipid Syndrome Recurrence but Fails to Prevent Chronic Vascular Changes Guillaume Canaud, Nassim Kamar, Dany Anglicheau, American Journal of Transplantation	2013	106
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept Nathalie Chavarot, Antoine Morel, Marianne Leruez‐Ville, American Journal of Transplantation	2021	103
Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA Lucile Amrouche, Olivier Aubert, Caroline Suberbielle, Transplantation	2017	80
COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities Nathalie Chavarot, Juliette Gueguen, Guillaume Bonnet, American Journal of Transplantation Solid Organ TransplantationRenal PathologyTransplantation MedicineCovid-19 EpidemiologyCovid-19	2020	78
Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults Olivier Gribouval, Olivia Boyer, Aurélie Hummel, Kidney International GlomerulonephritisGenetic CausesGenetic DisorderMedicineGenetics	2018	73
Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor–Intolerant Graft Recipients of Kidneys From Extended‐Criteria Donors Yannick Le Meur, Florence Aulagnon, Dominique Bertrand, American Journal of Transplantation Transplant RecipientsRenal PathologyTransplantation MedicineEarly SwitchEcd Kidneys	2015	65

Page 1